Development of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
Cancer remains one of the leading causes of morbidity and mortality worldwide, necessitating the continuous exploration of innovative treatment strategies. The development of novel drug delivery systems for targeted cancer therapy has emerged as a promising approach to enhance the efficacy and reduce the systemic toxicity of anticancer agents. This thesis presents a comprehensive investigation into the design, development, and evaluation of advanced drug delivery systems tailored for targeted cancer therapy. The introduction sets the stage by highlighting the significance of targeted drug delivery in improving the therapeutic outcomes of cancer treatment. The background of the study provides a detailed overview of current challenges in cancer therapy, emphasizing the limitations of conventional chemotherapy and the potential benefits of targeted delivery systems. The problem statement underscores the critical need for more effective and less toxic treatment modalities for cancer patients. The objectives of the study are outlined to elucidate the specific goals and research questions addressed in this thesis. The limitations of the study are acknowledged to provide a transparent view of the constraints and challenges encountered during the research process. The scope of the study delineates the boundaries within which the research is conducted, defining the specific cancer types and drug delivery approaches investigated. The significance of the study is discussed in terms of its potential impact on advancing the field of cancer therapy and improving patient outcomes. The structure of the thesis is presented to guide the reader through the organization of the research findings and discussions. Definitions of key terms are provided to ensure clarity and understanding of the terminology used throughout the thesis. The literature review chapter critically examines existing research and developments in the field of drug delivery for cancer therapy. Ten key themes are explored, including nanotechnology-based delivery systems, targeted drug delivery strategies, and personalized medicine approaches. The review highlights the latest advancements and challenges in the field, laying the foundation for the subsequent research chapters. The research methodology chapter details the experimental design, materials, and methods employed in developing and evaluating novel drug delivery systems. Eight key components are discussed, encompassing formulation development, characterization techniques, in vitro and in vivo evaluation methods, and data analysis procedures. The methodological approach is designed to ensure robust and reliable research outcomes. The discussion of findings chapter presents a detailed analysis and interpretation of the research results obtained from the experimental studies. Key findings related to the efficacy, safety, and targeting efficiency of the developed drug delivery systems are discussed in depth. The implications of the findings are critically evaluated in the context of advancing targeted cancer therapy. In the conclusion and summary chapter, the key findings, contributions, and implications of the research are succinctly summarized. The potential clinical applications and future directions for further research are discussed to guide future studies in the field. Overall, this thesis provides valuable insights and advancements in the development of novel drug delivery systems for targeted cancer therapy, with the ultimate goal of improving treatment outcomes and patient quality of life. Keywords Cancer therapy, Drug delivery systems, Targeted therapy, Nanotechnology, Personalized medicine, Efficacy, Safety, Innovation.